VARNAVAS, ANTONIOS
 Distribuzione geografica
Continente #
NA - Nord America 1.794
EU - Europa 916
AS - Asia 341
AF - Africa 27
SA - Sud America 5
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.089
Nazione #
US - Stati Uniti d'America 1.792
SE - Svezia 250
UA - Ucraina 226
IT - Italia 159
CN - Cina 157
HK - Hong Kong 86
FI - Finlandia 69
GB - Regno Unito 55
TR - Turchia 50
SG - Singapore 44
BG - Bulgaria 33
IE - Irlanda 32
FR - Francia 28
SN - Senegal 27
DE - Germania 26
BE - Belgio 13
CH - Svizzera 7
BR - Brasile 4
NL - Olanda 4
RU - Federazione Russa 4
AU - Australia 3
ES - Italia 3
GR - Grecia 3
CA - Canada 2
EU - Europa 2
HR - Croazia 2
JP - Giappone 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CZ - Repubblica Ceca 1
IN - India 1
NZ - Nuova Zelanda 1
PL - Polonia 1
Totale 3.089
Città #
Ann Arbor 322
Woodbridge 224
Chandler 201
Jacksonville 197
Houston 156
Fairfield 129
Wilmington 105
Hong Kong 86
Beijing 69
Princeton 66
Ashburn 57
Seattle 51
Izmir 47
Cambridge 43
Trieste 40
Sofia 33
Dublin 32
Milan 28
Singapore 28
Dakar 27
Boardman 18
Bremen 16
Columbus 16
Brussels 13
San Diego 12
Hefei 11
Shanghai 10
Auburn Hills 7
Buffalo 7
Verona 7
Chicago 6
Düsseldorf 6
Los Angeles 6
Mestre 6
Norwalk 5
Santa Clara 5
Andover 4
Bern 4
Bologna 4
Dearborn 4
Des Moines 4
Jinan 4
Nanjing 4
Torre Del Greco 4
Catalao 3
Helsinki 3
Indiana 3
Kansas City 3
San Francisco 3
Shenyang 3
Venice 3
Amsterdam 2
Baltimore 2
Ferrara 2
Foligno 2
Fuzhou 2
Grafing 2
Guangzhou 2
Jinhua 2
Kocaeli 2
Ningbo 2
Phoenix 2
Sacile 2
Tokyo 2
Wuhu 2
Xian 2
Zurich 2
Auckland 1
Avigliano 1
Brno 1
Campinas 1
Canton 1
Carpignano 1
Changsha 1
Clearwater 1
Costa Mesa 1
Dallas 1
Dubai 1
Frankfurt am Main 1
Fremont 1
Grammichele 1
Haikou 1
Jiaxing 1
Kilburn 1
Kunming 1
Malo 1
Maniago 1
New York 1
Newcastle upon Tyne 1
Ottawa 1
Pamplona 1
Reading 1
Rome 1
Sabadell 1
Salerno 1
San Vito Al Tagliamento 1
Sarnia 1
Spoleto 1
Stockholm 1
Sydney 1
Totale 2.210
Nome #
New Anthranilic Acid Based Antagonists with High Affinity and Selectivity for the Human Cholecystokinin Receptor 1 (hCCK1-R) 211
Anthranilic acid derivatives: A new class of non-peptide CCK1 receptor antagonists 147
Synthesis of N-terminal substituted anthranilic acid dimer derivatives for evaluation on CCK receptors. 147
N-TERMINAL ANTHRANOYL-PHENYLALANINE DERIVATIVES AS CCK1 RECEPTOR ANTAGONISTS: THE FINAL APPROACH 136
ANTHRANILIC ACID BASED CCK1 RECEPTOR ANTAGONISTS AND CCK-8 HAVE A COMMON STEP IN THEIR "RECEPTOR DESMODYNAMIC PROCESSES" 132
C-terminal anthranoyl-anthranilic acid derivatives and their evaluation on CCK receptors. 126
Anthranilic acid based CCK1 receptor antagonists: Blocking the receptor with the same ‘words’ of the endogenous ligand 126
TWENTY YEARS OF NON-PEPTIDE CCK1 RECEPTOR ANTAGONISTS: ALL THAT GLITTERS IS NOT GOLD 122
Anthranilic acid based CCK1 receptor antagonists 118
Anthranilic acid based CCK1 antagonists: the 2-indole moiety may represent a “needle” according to the recent homonymous concept. 117
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK 109
Anthranyl derivatives having an anticholecystokinin activity (anti-CCK1), a process for their preparation, and pharmaceutical use thereof 103
Novel Anthranilic Acid Derivates with Nanomolar CCK-A Receptor Affinity 103
Effect of High Hydrostatic Pressare on Cathalytic Behaviour of Pseudomonas Lipase 102
Derivati antranilici ad attività anticolecistochininica (anti-CCK-1), procedimento per la loro preparazione e loro uso farmaceutico 100
2D-QSAR and 3D-QSAR/CoMFA analyses of the N-terminal substituted anthranilic acid based CCK1 receptor antagonists: ‘Hic Rhodus, hic saltus’ 97
Synthesis of new anthranilic acid dimer derivatives and their evaluation on CCK receptors. 96
Anthranilic Acid Based CCK1 Receptor Antagonists: Preliminary Investigation On Their Second “Touch point” 91
Anthranyl derivatives having an anticholecystokinin activity (anti-CCK1), a process for their preparation, and pharmaceutical use thereof. 90
Anthranoyl-anthranilic acid: A template for the development of a new class of cholecystokinin receptor ligands. 85
Kinetic investigation of the aqueous stability and antitumor activity of a hydrosoluble diaryltriazene, AVIS, related to the antimetastatic agent DM-COOK 85
The X-ray diffraction crystal structure determination and electron impact fragmentations of the gaseous ions of 3-(p-chlorophenyl)-1-methyltriazene-1-oxide and its 3-methyl derivative 83
Antineoplastic action of p-(3-methyl-1-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK 78
Anthranyl derivatives having an anticholecystokinin activity (anti-CCK1), a process for their preparation, and pharmaceutical use thereof 75
Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt 75
Quinazolinone derivatives: Synthesis and binding evaluation on cholecystokinin receptors. 73
Kinetic study employing UV derivative spectroscopy of DM-COOK, antitumor and antimetastatic agent. 60
Synthesis of new benzodiazepine-derivatives as potential cholecystokinin antagonists”. 56
Quinolone derivatives: Synthesis and binding evaluation on cholecystokinin receptors. 53
Synthesis and antitumor activity of hydrosoluble triazenes, analogs of DM-COOK 52
Stability of the chemical xenogenization inducer, MM-COOK, possible metabolite of the antimetastatic agent, DM-COOK. A kinetic investigation. 51
Simultaneous determination of ionization constant and partition coefficient of DM-COOK, a potent antimetastatic agent. 50
Synthesis and antitumor activity of aminoacid derivatives of the antimetastatic agent DM-COOK. 47
Totale 3.196
Categoria #
all - tutte 9.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020444 0 13 13 92 18 65 60 57 27 44 49 6
2020/2021348 42 9 41 49 11 39 6 39 6 50 11 45
2021/2022436 10 35 11 65 6 31 10 14 48 43 34 129
2022/2023551 63 92 38 85 58 99 1 52 45 3 11 4
2023/2024284 17 11 23 21 37 1 34 93 5 8 23 11
2024/202531 10 21 0 0 0 0 0 0 0 0 0 0
Totale 3.196